|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.5990 USD | -0.99% |
|
-6.94% | -90.21% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
d6cb757e18712c.baF_EQpmxjuJ5PC9drv6lXLHw-so3H6Fe-nr6Ya6Sm0.HpcmZF5L8AzloJroOv6XwwiMtbxbqTC2HLa-rbPPHxkb-wopSC-oWtm2oQ~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +1,831.13% | |||||
| +32.97% | |||||
| +14.74% | |||||
| +38.45% | |||||
| +12.07% | |||||
| +18.26% | |||||
| +44.87% | |||||
| +38.06% | |||||
| +24.78% | |||||
| +8.87% | |||||
| Average | +206.42% | |||||
| Weighted average by Cap. | +26.83% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5990USD
Average target price
11.68USD
Spread / Average Target
+1,850.47%
High Price Target
15.05USD
Spread / Highest target
+2,412.52%
Low Price Target
8.000USD
Spread / Lowest Target
+1,235.56%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
